Schedule for Dissemination workshop for “Tracing Pharma in South Asia”
Day One: Academic papers
- 5th April 2009 | Summit Hotel, Kupondole, Lalitpur
- 9:00am-9:30am: Introductory Remarks
- Pratyoush Onta (Secretary, Martin Chautari)
Roger Jeffery (University of Edinburgh, Scotland)
- Pratyoush Onta (Secretary, Martin Chautari)
- 9:30am-11:00am: Paper Presentation
- 1. National (non-) regulation in a global pharmaceutical world
Professor Roger Jeffery, Discussant: Prajwol J. Pandey (Corporate Executive, Lomus Pharmaceuticals) - 2. Trials and evidence in relation to health policy: The case of Tuberculosis in Nepal and India
Ian Harper, Discussant: Sushil Baral (DfID)
- 1. National (non-) regulation in a global pharmaceutical world
- 11:15am-1:00pm: Paper Presentation
- 3. Labour Management: Oxytocin in the context of the Millennium Development Goals
Professor Patricia Jeffery and Petra Brhlikova, Discussant: Dr. Rita Thapa - 4. Disputing Distribution: Ethics and Pharmaceutical Regulation in Nepal
Nabin Rawal, Madhusudan Subedi and Ian Harper, Discussant: Bhupendra B. Thapa (Chief Drug Administrator, MoH)
- 3. Labour Management: Oxytocin in the context of the Millennium Development Goals
- 2:00pm-3:30pm: Paper Presentation
- 5. Prozac on the loose: Rethinking the "treatment gap" for depression in South Asia
Stefan Ecks, Discussant: Mary Des Chene (Anthropologist) - 6. Global Burden of Disease measure for Depression – time for a rethink
Professor Allyson Pollock and Petra Brhlikova, Rachel Manners
Discussant: Dr. Pushpa Sharma (Associate Professor, Kathmandu University)
- 5. Prozac on the loose: Rethinking the "treatment gap" for depression in South Asia
- 9:00am-9:30am: Introductory Remarks
Day Two: Policy oriented presentations and media dissemination
- 6th April 2009 | Summit Hotel, Kupondole, Lalitpur
- 9:00 – 13:00: Presentations and discussion
- Session Chair: Dr. Sharad Onta, Vice-Chair and Executive Chief, HIV/AIDS and STI Control Board
General Discussion
- Session Chair: Dr. Sharad Onta, Vice-Chair and Executive Chief, HIV/AIDS and STI Control Board
- 9:00 – 13:00: Presentations and discussion